Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (NCT07809646) titled 'Cl-Pharm-IBS-ML-2026' on Sept. 3.

Study Type: Observational

Primary Sponsor: Tanta University

Condition: IBS

Intervention: Other: Questionnaire and Physical Exam

Recruitment Status: Not recruiting

Date of First Enrollment: September 20, 2026

Target Sample Size: 500

To know more, visit https://clinicaltrials.gov/study/NCT07809646

Published by HT Digital Content Services with permission from Health Daily Digest....